Cargando…
Novel Platforms for the Development of a Universal Influenza Vaccine
Despite advancements in immunotherapeutic approaches, influenza continues to cause severe illness, particularly among immunocompromised individuals, young children, and elderly adults. Vaccination is the most effective way to reduce rates of morbidity and mortality caused by influenza viruses. Frequ...
Autores principales: | Kumar, Arun, Meldgaard, Trine Sundebo, Bertholet, Sylvie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877485/ https://www.ncbi.nlm.nih.gov/pubmed/29628926 http://dx.doi.org/10.3389/fimmu.2018.00600 |
Ejemplares similares
-
Single-Cell Analysis of Antigen-Specific CD8+ T-Cell Transcripts Reveals Profiles Specific to mRNA or Adjuvanted Protein Vaccines
por: Meldgaard, Trine Sundebo, et al.
Publicado: (2021) -
B Cells and Functional Antibody Responses to Combat Influenza
por: Lofano, Giuseppe, et al.
Publicado: (2015) -
Bacteriophage T4 Vaccine Platform for Next-Generation Influenza Vaccine Development
por: Li, Mengling, et al.
Publicado: (2021) -
Editorial: Influenza Virus Vaccines and Immunotherapies
por: Kumar, Arun, et al.
Publicado: (2015) -
Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines
por: Sridhar, Saranya
Publicado: (2016)